Targeted hepatic delivery of ezetimibe via red blood cell-coated nanoparticles for the treatment of non-alcoholic fatty liver disease through inflammation modulation.

Ozgur Esim, Seyma Adatepe, Okan Ali Aksoy, Berk Alp Goksel, Tugba Yilmaz, Baris Baykal, Çigdem Yucel, Sevilay Erdogan Kablan, Cemil Can Eylem, Engin Kocak, Hakan Erdogan, Cansel Kose Ozkan, Emirhan Nemutlu, Ayhan Savaser, Yalçın Ozkan